Uplarafenib
Uplarafenib (B-Raf IN 10) (Compound C09) is a BRAF inhibitor with an IC50 between 50 and 100 nM. Uplarafenib shows antitumor activity[1].
Product Specifications
CAS Number
1425485-87-5
Product Name Alternative
B-Raf IN 10
UNSPSC
12352005
Target
Raf
Type
Reference compound
Related Pathways
MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/uplarafenib.html
Purity
99.63
Solubility
DMSO : 100 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(C1=C(F)C(NS(=O)(CCC)=O)=CC(F)=C1F)C2=CC=C3N=CC(N4CCOCC4)=NC3=C2
Molecular Formula
C22H21F3N4O4S
Molecular Weight
494.49
References & Citations
[1]Yong-Liang Zhu, et al. Certain Chemical Entities, Compositions, and Methods. Patent US20130053384 A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
B-Raf
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6504550-01 0.2 mL
UBQLN2, NT (Ubiquilin 2, Protein Linking IAP with Cytoskeleton-2, PLIC-2, hPLIC-2, Ubiquitin-like Product Chap1/Dsk2, DSK2 Homolog, Chap1, N4BP4, PLIC2, HRIHFB2157) (PE)
Sign In for Pricing
View Details MBS6504550-02 5x 0.2 mL
UBQLN2, NT (Ubiquilin 2, Protein Linking IAP with Cytoskeleton-2, PLIC-2, hPLIC-2, Ubiquitin-like Product Chap1/Dsk2, DSK2 Homolog, Chap1, N4BP4, PLIC2, HRIHFB2157) (PE)
Sign In for Pricing
View Details